Login
Toggle sidebar

Lint: ioflupane-i-123

ioflupane-i-123
Isotope Notation
error

"Ioflupane is the international non-proprietary name of the radiolabeled cocaine analogue usually abbreviated to [123I]FP-CIT: N-(3-Fluoropropyl)-2β-carbomethoxy-3β-(4-[123I]iodophenyl)nortropane. I-123 ioflupane is available worldwide and marketed under the trade name DaTSCANTM."

Line 9:122 · Write the isotope as symbol-mass, e.g. F-18, not '123I'.

"Ioflupane is the international non-proprietary name of the radiolabeled cocaine analogue usually abbreviated to [123I]FP-CIT: N-(3-Fluoropropyl)-2β-carbomethoxy-3β-(4-[123I]iodophenyl)nortropane. I-123 ioflupane is available worldwide and marketed under the trade name DaTSCANTM."

Line 9:197 · Write the isotope as symbol-mass, e.g. F-18, not '123I'.
Acronyms
warning

"Ioflupane is the international non-proprietary name of the radiolabeled cocaine analogue usually abbreviated to [123I]FP-CIT: N-(3-Fluoropropyl)-2β-carbomethoxy-3β-(4-[123I]iodophenyl)nortropane. I-123 ioflupane is available worldwide and marketed under the trade name DaTSCANTM."

Line 9:133 · 'FP-CIT' has no definition. Spell it out if it's unfamiliar to the audience.

"Ioflupane is the international non-proprietary name of the radiolabeled cocaine analogue usually abbreviated to [123I]FP-CIT: N-(3-Fluoropropyl)-2β-carbomethoxy-3β-(4-[123I]iodophenyl)nortropane. I-123 ioflupane is available worldwide and marketed under the trade name DaTSCANTM."

Line 9:316 · 'TM' has no definition. Spell it out if it's unfamiliar to the audience.
Emphasis
warning

"Ioflupane is the international non-proprietary name of the radiolabeled cocaine analogue usually abbreviated to [123I]FP-CIT: N-(3-Fluoropropyl)-2β-carbomethoxy-3β-(4-[123I]iodophenyl)nortropane. I-123 ioflupane is available worldwide and marketed under the trade name DaTSCANTM."

Line 9:141 · Italics should be used only in exceptional circumstances: '<em>N</em>'
Headings Valid
warning

Expected headings

  • H1 Terminology
  • H1 Usage
  • H1 Epidemiology
  • H2 Risk factors
  • H2 Associations
  • H1 Clinical presentation
  • H2 Complications
  • H1 Diagnosis
  • H2 Diagnostic criteria
  • H2 Diagnostic clues
  • H1 Pathology
  • H2 Aetiology
  • H2 Location
  • H2 Classification
  • H2 Macroscopic appearance
  • H2 Microscopic appearance
  • H2 Immunophenotype
  • H2 Markers
  • H2 Genetics
  • H1 Radiographic features
  • H2 Plain radiograph
  • H2 Mammography
  • H2 Antenatal ultrasound
  • H2 Transoesophageal echocardiography
  • H2 Ultrasound
  • H2 CT
  • H3 Dual-energy CT
  • H2 Angiography (DSA)
  • H2 MRI
  • H2 CT/MRI
  • H2 Nuclear medicine
  • H3 PET-CT
  • H3 PET-MRI
  • H1 Radiology report
  • H1 Treatment and prognosis
  • H2 Complications
  • H1 History and etymology
  • H1 Differential diagnosis
  • H2 Clinical differential diagnosis
  • H1 Practical points
  • H1 See also

"Characteristics"

Line 2:1 · "Characteristics" is not a recognised heading for this article type.

"Uses, doses and timing"

Line 11:1 · "Uses, doses and timing" is not a recognised heading for this article type.
Oxford Comma
suggestion

"Uses, doses and timing"

Line 11:5 · Use the Oxford comma in 'Uses, doses and timing'.
Links
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0